The budding yeast Saccharomyces cerevisiae was used as a model system to study the function of the adenovirus E1A oncoprotein. Previously we demonstrated that expression of the N-terminal 82 amino acids of E1A in yeast causes pronounced growth inhibition and speci®cally interferes with SWI/SNF-dependent transcriptional activation. Further genetic analysis identi®ed the yeast transcription factor Adr1 as a high copy suppressor of E1A function. Transcriptional activation by Adr1 requires interaction with co-activator proteins Ada2 and Gcn5, components of histone acetyltransferase complexes including ADA and SAGA. Analysis of mutant alleles revealed that several components of the SAGA complex, including proteins from the Ada, Spt, and Taf classes were required for E1A-induced growth inhibition. Growth inhibition also depended on the Gcn5 histone acetyltransferase, and point mutations within the Gcn5 HAT domain rendered cells E1A-resistant. Also required was SAGA component Tra1, a homologue of the mammalian TRRAP protein which is required for c-myc and E1A induced cellular transformation. Additionally, Gcn5 protein could associate with E1A in vitro in a manner that depended on the N-terminal domain of E1A, and Tra1 protein was coimmunoprecipitated with E1A in vivo. These results indicate a strong requirement for intact SAGA complex for E1A to function in yeast, and suggest a role for SAGA-like complexes in mammalian cell transformation.
Introduction
The adenovirus E1A proteins are potent oncoproteins, capable of immortalizing primary rodent cells in culture, and cooperating with the Ha-ras or adenovirus E1B oncoproteins to transform cells (Dyson and Harlow, 1992; Ruley, 1983; Van den Elsen et al., 1983) . The oncogenic properties of E1A derive from its function as a transcriptional regulator, which results in speci®c alterations in the normal cellular transcriptional program. During adenovirus infection of permissive human cells, E1A activates viral gene transcription to produce proteins necessary for viral replication (reviewed in Flint and Shenk, 1989) . In this context, E1A also modi®es host cell transcription to create a cellular environment favorable for the production of virus. Expression of E1A, independent of viral infection, can induce DNA synthesis, inhibit dierentiation, trigger apoptosis or result in immortalization depending upon the cellular context (Bayley and Mymryk, 1994) .
The major products of the E1A gene are two related proteins of 289 and 243 amino acids. E1A 289 contains a unique region called CR3, which is primarily responsible for activation of viral transcription (Flint and Shenk, 1989) . E1A 243 lacks CR3, but is otherwise identical to E1A 289 . E1A 243 is an inecient activator of viral transcription, but is able to regulate cellular transcription and function in transformation assays (Berk et al., 1998; Flint and Shenk, 1989) . Three functional domains of E1A 243 encompass amino acids 2 ± 25, 36 ± 81, and 124 ± 140, and are referred to as the N-terminal domain, CR1 and CR2, respectively. Mutation of any of these domains alters cellular transcriptional regulation by E1A, and renders it unable to transform cells. The N-terminal domain, CR1, and CR2 function by binding to critical cellular proteins, including Rb, p107, p130, p300/CBP and P/CAF, which govern the cell cycle and transcriptional regulatory pathways (Bayley and Mymryk, 1994; Chakravarti et al., 1999) . Binding of E1A to these proteins alters their interaction with other cellular proteins and/or their intrinsic activity. For example, E1A binding to Rb prevents the association of Rb with members of the E2F family of transcription factors. Free E2F is then able to activate the transcription of cellular genes required for DNA replication (Bayley and Mymryk, 1994) . The interaction of E1A with Rb is essential to the transformation function of E1A and highlights the important role of E1A binding partners in governing growth and transcription.
The identi®cation of additional molecular targets of E1A is important to our understanding of the pathways and proteins functioning in cellular transcriptional regulation and growth control. To this end, we have described the use of Saccharomyces cerevisiae as a model system to characterize novel functions of E1A (Miller et al., 1995 (Miller et al., , 1996 . We and others have observed that expression of E1A in yeast inhibits cell growth and causes accumulation in the G1 phase of the cell cycle (Handa et al., 1987; Miller et al., 1995; Sang et al., 2001) . Mutational analysis has indicated that the domains required for transformation and transcriptional regulation in mammalian cells are also required for E1A-dependent growth inhibition in yeast, suggesting that yeast can serve as a relevant model for E1A functional analysis. Speci®cally, the N-terminal and CR1 domains (i.e. the p300/CBP binding region) are necessary and sucient for induction of the slow growth phenotype in yeast (Miller et al., 1995 (Miller et al., , 1996 Sang et al., 2001) . In addition, function of the Nterminal and CR1 domains requires cAMP signaling in both yeast and mammalian systems (Miller et al., 1995) .
Our genetic analysis of E1A function revealed a strict requirement for the SWI/SNF chromatin remodeling complex, which stimulates transcriptional activation of a variety of genes by facilitating access of sequence-speci®c DNA binding proteins to promoter sequences (Cairns, 1998; Kornberg and Lorch, 1999; Peterson, 1998) . Strains carrying mutations in SWI/ SNF components are resistant to E1A-induced growth inhibition. Moreover, expression of E1A in wild-type cells leads to a speci®c loss of SW1/SNF-dependent transcriptional activation, strongly suggesting that the SWI/SNF complex is a functional target of E1A (Miller et al., 1996) . Studies in mammalian systems have also revealed a link between E1A and chromatin structure regulation. Histone acetylation is a modi®ca-tion of chromatin associated with the activation of transcription . E1A binds directly to the histone acetyltransferases (HATs) p300/CBP and P/CAF, and such binding has been reported to have both positive and negative eects on HAT activity (Aitsiali et al., 1998; Chakravarti et al., 1999; Hamamori et al., 1999; Reid et al., 1998; Yang et al., 1996) . However, the functional consequences of the interaction of E1A with HAT activities in mammalian cells are not clear with respect to transcriptional regulation and transformation by E1A.
Here we report the results of our further genetic analysis of E1A function in yeast. We show that in addition to a requirement for the SWI/SNF chromatin remodeling complex, E1A also requires the SAGA complex, whose components include the Gcn5 histone acetyltransferase, a subset of TBP-associated factors (Tafs), several Spt proteins, and Tra1, a homologue of mammalian TRRAP protein that functions in E1A and c-myc dependent cellular transformation. Furthermore we show that E1A can associate with Gcn5 and Tra1, indicating that the SAGA complex is a direct target of E1A.
Results

High-copy suppression analysis in yeast
To explore the mechanisms of E1A-induced inhibition of growth and SWI/SNF-dependent transcription, we performed a high-copy suppression analysis of Gal4-E1A 1 ± 82 . Gal4-E1A 1 ± 82 is a fusion protein consisting of the DNA binding domain of Gal4 and the Nterminal 82 amino acid residues of E1A. Previously we have shown that Gal4-E1A 1 ± 82 inhibits yeast cell growth and speci®cally blocks SWI/SNF-dependent transcription (Miller et al., 1995 (Miller et al., , 1996 . These eects do not require the Gal4 DNA binding domain, since full-length E1A 243 protein, without the Gal4 DNA binding domain, behaves identically to Gal4-E1A 1 ± 82 . However, the N-terminal domain of E1A is unstable when expressed alone (Miller et al., 1995) .
Yeast strain GGY1 : 171 was co-transformed with a high-copy yeast genomic library and plasmid pGal4-E1A 1 ± 82 to identify library clones able to suppress E1A-induced growth inhibition. Colonies with restored growth were isolated and the suppressing plasmids recovered. To determine if suppression was due to a speci®c eect on E1A function, each isolated library clone was tested for the ability to suppress the function of Gal4-VP16, which has also been shown to inhibit yeast growth (Berger et al., 1992) . Clones that speci®cally suppressed Gal4-E1A 1 ± 82 function but not Gal4-VP16 function were further characterized. Strains with restored growth were also subjected to Western blot analysis to con®rm that they continued to express Gal4-E1A 1 ± 82 in the presence of the suppressing library clone (data not shown). A total of four library clones were identi®ed that speci®cally suppressed Gal4-E1A 1 ± 82 , but not Gal4-VP16. Three of the suppressor clones contained large genomic fragments that spanned several genes. The speci®c open reading frame responsible for the suppression of growth inhibition by E1A has not been identi®ed for these clones. The fourth clone contained only a single complete open reading frame and was studied further.
Transcription factor Adr1 suppresses E1A function
Our previous ®ndings demonstrating a connection between E1A and SWI/SNF-dependent transcription suggested that E1A can act at the level of chromatin structure regulation (Miller et al., 1996) . The identity of one of the suppressing clones immediately implied a link to transcription and chromatin structure regulation. Figure 1 shows that over-expression of transcription factor Adr1 can suppress the function of Gal4-E1A 1 ± 82 . Cells were transformed with plasmids expressing Gal4-E1A 1 ± 82 , Adr1, or the two in combination. Serial dilutions of cultures were spotted onto plates and incubated at 288C. Expression of Gal4-E1A 1 ± 82 caused a pronounced inhibition of growth while over-expression of Adr1 suppressed this eect. Over-expression of Adr1 alone had no eect on growth.
In addition to its eects on growth, E1A blocks SWI/SNF-dependent transcriptional activation of the INO1 and SUC2 genes (Miller et al., 1996) . Therefore we asked if over-expression of Adr1 could suppress this eect of E1A as well. Figure 2 shows the results of Northern blot analysis for activation of the INO1 gene, which is induced in a SWI/SNF-dependent manner by inositol starvation (Peterson and Herskowitz, 1992) . Gal4-E1A 1 ± 82 signi®cantly inhibited activation of INO1, and this eect was reversed by over-expression of Adr1. Again, there was no eect of Adr1 alone on induction of INO1. We conclude that Adr1 can suppress E1A function at the level of transcription, as well as at the level of cell growth inhibition.
We considered the possibility that Adr1 protein could be acting as a suppressor by binding to E1A directly and interfering with its function. GST pulldown assays were performed with recombinant E1A and Adr1 proteins to test this possibility, but no evidence for an interaction was observed (not shown).
Furthermore, an adr1 null strain was as sensitive as the parental wild-type strain to the growth inhibitory eects of E1A, indicating that Adr1 is not required for E1A function. Since over-expression of Adr1 speci®cally suppresses E1A function, the most likely explanation for these data is that high-copy suppression by Adr1 is due to an interaction between Adr1 and the transcriptional machinery that alters the response to E1A.
Transcriptional co-activator proteins are required for E1A function Adr1 activates transcription of several genes in yeast through direct interaction with components of the TFIID complex and transcriptional co-activators including Ada2 and the HAT Gcn5 (Chiang et al., 1996; Komarnitsky et al., 1998) . Gcn5 serves as a coactivator of transcription by acetylation of speci®c lysine residues in the amino-terminal tails of nucleosomal histones, which is associated with transcriptional activation (Kuo et al., 1996 (Kuo et al., , 1998 . Gcn5 and Ada2 are common components of at least two HAT coactivator complexes, termed ADA and SAGA (Grant et al., 1997; Pollard and Peterson, 1997) . We hypothesized that over-expression of Adr1 suppresses E1A function by modifying the activity of ADA or SAGA. This hypothesis further suggested that components of these complexes might be required for E1A function.
To examine this possibility, we tested gcn5, ada2, and ada3 null strains to determine if they support E1A-induced growth inhibition. These strains were transformed with pGal4-E1A 1 ± 82 , and serial dilutions of cultures were spotted onto selective media and grown at 288C. As shown in Figure 3a , the gcn5, ada2, and ada3 null strains were completely resistant to growth inhibition by E1A, whereas the wild-type parent exhibited substantial sensitivity. As shown in Figure  3b , Western blot analysis con®rmed that Gal4-E1A 1 ± 82 was expressed in wild-type, gcn5 and ada2. We conclude that the Ada2, Ada3, and Gcn5 components of the ADA and SAGA histone acetyltransferase complexes are required for E1A function in yeast.
E1A function requires the Gcn5 HAT domain
Functional domains of Gcn5 have been mapped by deletion analysis and include a minimal HAT domain (residues 170 ± 253), an Ada2-interaction domain (residues 253 ± 280), and a bromodomain (residues 350 ± 440). Residues 95 ± 261 are required for maximal in vitro HAT activity, and residues 95 ± 280 are required for complementation of growth and transcriptional defects of the gcn5 null allele in vivo .
To explore the relationship between the HAT activity of Gcn5 and the function of E1A, we tested a series of HAT-domain point mutants for their ability to support E1A-induced growth inhibition. A yeast strain deleted for GCN5 was co-transformed with gcn5 mutant expression vectors and pGal4-E1A 1 ± 82 . Trans- Figure 1 Adr1 is a high-copy suppressor of E1A-induced growth inhibition. Wild-type strain MSY596 was transformed with control vector or plasmids expressing either Gal4-E1A 1 ± 82 , Adr1, or the two in combination, as indicated. In this and all subsequent experiments, 10-fold serial dilutions of liquid cultures of the transformants, beginning with 1610 7 cells/ml, were spotted on plates and incubated at 288C for 2 days Figure 2 Adr1 suppresses the eect of E1A on SWI/SNFdependent transcription. MSY596 cells expressing the indicated proteins were grown exponentially in medium containing 100 mM (+) or no (7) inositol and harvested for total cellular RNA isolation as described in Materials and methods. The RNAs were assayed by Northern blot analysis with an INO1-speci®c probe formants were selected and plated at 288 to score the gcn5 mutants for their ability to support growth inhibition by E1A. The results are presented in Table  1 along with a summary of the growth complementation and transcriptional phenotypes of the various gcn5 constructs as reported previously by Kuo et al. (1998) . We observed that mutant gcn5 constructs that fail to support growth and transcription in vivo also failed to support E1A-induced growth inhibition. These results indicate a strong requirement for the Gcn5 HAT domain in E1A function.
SAGA components required for E1A function
Our observations that the co-activator proteins Gcn5, Ada2 and Ada3 are required for E1A function, and that E1A requires the HAT domain of Gcn5 to inhibit growth, led us to hypothesize that E1A function is dependent on the SAGA or ADA complexes. All but one of the known components of the ADA complex are also members of SAGA, but SAGA contains many additional components (Eberharter et al., 1999; Grant et al., 1998a,b; Sterner et al., 1999) . We therefore tested the possibility that additional SAGA-speci®c proteins are required for E1A function using a de®ned set of mutant alleles. SAGA has been shown to consist of proteins from several functional and genetic classes including Ada, Spt, and Taf. We tested the dependence of E1A function on representative components from each class.
The ADA class was initially de®ned to include genes required for function of the acidic activator GAL4-VP16 in yeast (Berger et al., 1990) . In addition to ADA2, ADA3, and GCN5(ADA4), ADA1 and ADA5 are members of this class, and the Ada1 and Ada5 proteins are components of the SAGA complex. Loss of either Ada1 or Ada5 has severe eects on the structural integrity of SAGA (Grant et al., 1997; Sterner et al., 1999) . We tested an ada1 null strain to determine if it was sensitive to growth inhibition by E1A. The wild-type parent and ada1 null strains were transformed with a plasmid expressing Gal4-E1A 1 ± 82 . Serial dilutions were then spotted onto selective media and grown at 288C. As shown in Figure 4 , the ada1 null strain is completely resistant to growth inhibition by E1A. Since Ada1 is a component of SAGA but not the ADA complex, this result indicates that Ada1 is required for E1A function in yeast and that an intact SAGA complex may be a functional target of E1A.
Mutation of the SPT genes suppresses transcriptional defects caused by Ty or d insertions at the yeast HIS4 or LYS2 loci Simchen et al., 1984; Winston et al., 1984) . Based on shared mutant phenotypes, these genes have been divided into two sub-classes. One sub-class contains genes encoding histones and other chromatin associated proteins. The other sub-class consists of SPT3, SPT8, SPT7, SPT20/ADA5 and SPT15 (TATA box binding protein, TBP). With the exception of TBP, all members of this sub-class co-purify with the SAGA complex. Loss of Spt3 or Spt8 has minor consequences for SAGA integrity, whereas loss of Spt7 or Spt20 completely disrupts SAGA structure (Grant et al., 1997; Sterner et al., 1999) . We tested spt3 and spt8 mutant strains to determine if they were sensitive to growth inhibition by E1A. The wild-type, spt3, and spt8 strains were transformed with pGal-E1A 1 ± 82 , and grown on selective medium at 288C. As shown in Figure 5a , deletion of SPT3 or SPT8 confers partial resistance to growth inhibition by E1A.
To further investigate the role of SPT genes in E1A function, we tested a representative SPT mutant from the other sub-class. Certain mutations in histones have been shown to confer an Spt phenotype, including a mutation in histone H4, hhf1-36 (Clark- Adams et al., 1988; Hirschhorn et al., 1992; Santisteban et al., 1997) . Wild-type or histone H4 mutant strain hhf1-36 were transformed with pGal4-E1A 1 ± 82 and spot tested at 288C. As shown in Figure 5b , the H4 mutant strain was strongly growth inhibited by E1A, similar to the wild-type parent. This result demonstrates that an Spt phenotype in general does not confer resistance to growth inhibition by E1A. Rather, our observations are consistent with a requirement for SAGA-associated Spt proteins for E1A to function.
TAF proteins are a set of TBP-associated factors, some of which co-purify with the SAGA complex (Grant et al., 1998a; Hahn, 1998) . SAGA-associated a b Figure 3 (a) E1A function requires Gcn5, Ada2, and Ada3. PSY316 (wild-type) or the indicated null derivatives were transformed with plasmids expressing either Gal4 1 ± 147 or Gal4-E1A 1 ± 82 . Serial dilutions of transformants grown in selective medium were spotted on plates and incubated at 288C for 2 days. (b) Immunoblot analysis of wild-type, gcn5 and ada2 strains expressing either Gal4 1 ± 147 or Gal4-E1A 1 ± 82 . Whole cell lysates were separated by SDS ± PAGE and analysed by Western blot using an anti-E1A antibody, M29, which is speci®c for the Nterminus of E1A. The lower band present in each lane represents a cross-reacting protein present in all of the yeast lysates TAFs include Taf90, Taf68, Taf60, Taf25 and Taf20. We tested two strains carrying taf90 temperature sensitive alleles to determine if they were sensitive to growth inhibition by E1A when grown at a semipermissive temperature. Strains containing wild-type TAF90, taf90-16, or taf90-17 were transformed with pGal4-E1A 1 ± 82 and spot tested at 25, 32 and 378C. As shown in Figure 6a , E1A inhibited growth of the mutant strains at 258C but not at 328C. These data indicate that Taf90 is required for E1A function.
Tsm1 and TAF145 are two Taf proteins that do not co-purify with SAGA. Yeast strains carrying temperature sensitive alleles of TAF145 or TSM1 were transformed with pGal4-E1A 1 ± 82 and spot tested at 28, 32 and 378C. As shown in Figure 6b , growth of the mutants was strongly inhibited by E1A at both permissive and semi-permissive temperatures, similar to the wild-type parent. These data indicate that Taf proteins unique to TFIID are not required for growth inhibition by E1A, and support the idea that E1A function depends upon additional activities of a subset of the Taf proteins that co-purify with SAGA.
In addition to the Ada, Spt and Taf proteins, Tra1 has been identi®ed as a component of the SAGA complex. Tra1 is the 400 kDa yeast homologue of the mammalian TRRAP protein, an ATM-related factor required for oncogenic transformation by c-myc or E1A (Grant et al., 1998b; McMahon et al., 1998; Saleh et al., 1998) . TRRAP is 58.9% similar to Tra1, and interestingly, binds to E1A in co-immunoprecipitation assays in mammalian cells (M Nikiforov and M Cole, personal communication). Accordingly, we tested if Tra1 is required for E1A-induced growth inhibition in yeast. Two strains containing temperature sensitive alleles of TRA1 and the wild-type parental strain were transformed with pGal4-E1A 1 ± 82 and serial dilutions were spotted onto selective media at 28, 33 and 378C (Figure 7) . Each strain carrying a tra1 temperature sensitive allele displayed resistance to E1A at the semipermissive temperature of 338C, and partial resistance was observed even at 288C. We conclude that Tra1 is required for E1A function. Taken together our data strongly argue that a functional SAGA complex is required for E1A to inhibit growth in yeast.
E1A 243 associates with SAGA components Gcn5 and Tra1
E1A 243 is known to associate with the histone acetyltransferases P/CAF, CBP, and p300, and P/CAF is a component of a mammalian SAGA-like complex (Ogryzko et al., 1998) . Therefore an association between E1A and yeast Gcn5 was tested using an in vitro GST pull-down assay. Bacterially expressed yeast GST-Gcn5 was puri®ed and immobilized using glutathione-agarose beads, and incubated with 35 Slabeled, in vitro translated E1A 243 . As shown in Figure  8 , E1A 243 speci®cally bound to GST-Gcn5 but not GST alone. Interestingly, the N-terminal domain of E1A was speci®cally required for this interaction, since E1A mutant D2-36 failed to bind GST-Gcn5. In contrast, E1A mutant D73-120, which is wild-type for N-terminal domain function (Kraus et al., 1994) , was as ecient as wild-type E1A in binding to Gcn5. Since the N-terminal 82 amino acids of E1A are sucient for inducing the slow-growth phenotype in yeast (Miller et al., 1995) , these data suggest that the E1A-Gcn5 interaction is relevant to the mechanism of growth inhibition.
Based on the high degree of relatedness between yeast Tra1 and mammalian TRRAP, and the ability of TRRAP to bind E1A and mediate E1A-induced cellular transformation, we probed for an E1A-Tra1 interaction in yeast cells. De®ned segments of TRA1 encoding 800 to 1000 amino acids were cloned as GSTfusions into a yeast expression vector under control of the galactose-inducible GAL1 gene promoter ( Figure  9a ). Strain MSY596 was co-transformed with each of these GST-Tra1 plasmids and plasmid pRS424/ 12SE1A, expressing full-length E1A 243 . We have shown previously that full-length E1A 243 functions in yeast identically to Gal4-E1A 1 ± 82 (Miller et al., 1995 (Miller et al., , 1996 . In addition, the full-length protein provides a Cterminal epitope for ecient co-immunoprecipitation assays. Whole cell lysates were prepared from the cotransformants and incubated with anti-E1A monoclo- (Kuo et al., 1998) Figure 4 E1A function requires Ada1. MSY596 (wild-type) and MSY596ada1 were transformed with plasmids expressing either Gal4 1 ± 147 or Gal4-E1A 1 ± 82 . Serial dilutions of transformants grown in selective medium were spotted on plates and incubated at 288C for 3 days nal antibody M73. To control for non-speci®c interactions with the precipitating antibody, lysates were also incubated with anti-FLAG antibody. The immune complexes were washed, separated by SDS ± PAGE, transferred to nitrocellulose and immunoblotted with anti-GST antibody. As shown in Figure  9b , Tra1 fragments 900 ± 1800, 1500 ± 2400, 2400 ± 3300, and 2600 ± 3745 each speci®cally co-immunoprecipitated with E1A, indicating that E1A can associate with at least two distinct regions of Tra1. The N-terminal 1 ± 1000 fragment of Tra1 did not co-precipitate with E1A, nor did the unrelated GST-CasDYXXP protein (Burnham et al., 2000) . The control anti-FLAG antibody failed to precipitate the GST-fusion proteins in the presence or absence of E1A. All of the GSTTra1 fusions were abundantly expressed in the presence or absence of E1A 243 . These results indicate that E1A 243 associates with Tra1 in living yeast cells, and, along with our demonstration of an E1A-Gcn5 interaction, strongly argue that the SAGA complex can function as speci®c target of E1A 243 .
Discussion
We have used the budding yeast Saccharomyces cerevisiae as a model system to genetically dissect adenovirus E1A function. We identi®ed a high copy suppressor of E1A toxicity in yeast, Adr1, that led us to examine the role of the SAGA complex in E1A function. Our results indicate that all of the major classes of proteins comprising the SAGA complex, including Ada, Spt, Taf and Tra1, are required for E1A to inhibit cell growth. Furthermore, since E1A function depends upon the HAT domain of Gcn5, our results suggest a strong requirement for a functional SAGA complex in order for E1A to inhibit yeast cell growth. In addition, we have identi®ed SAGA components Gcn5 and Tra1 as binding partners of E1A, supporting the idea that the SAGA complex is a direct target of E1A function. The SAGA complex consists of several functional modules that have been de®ned genetically and biochemically (Grant et al., 1998a,b; Sterner et al., 1999) . Among members of the ADA class, E1A function is highly dependent upon the HAT domain of Gcn5. Our results are consistent with data from mammalian systems that show a connection between E1A and the regulation of chromatin structure. E1A binds to the mammalian HAT proteins p300/CBP and P/CAF with either positive or negative eects on HAT activity (Aitsiali et al., 1998; Chakravarti et al., 1999; Hamamori et al., 1999; Reid et al., 1998; Yang et al., 1996) . P/CAF is a homologue of yeast Gcn5 and is Figure 5 E1A function requires SAGA-associated SPT genes. (a) Wild-type strains FY86 or FY630 and the indicated spt3 and spt8 mutant strains were transformed with plasmids expressing either Gal4 1 ± 147 or Gal4-E1A 1 ± 82 (as indicated). Transformants were grown on selective medium at 288C for 2 days. (b) MSY623 (wild-type) and MSY781 (hhf1-36) were transformed with plasmids expressing either Gal4 1 ± 147 or Gal4-E1A 1 ± 82 . Serial dilutions of transformants grown in selective medium were spotted on plates and incubated at 288C for 2 days present in at least one macromolecular complex with additional proteins that are similar to yeast SAGA components (Ogryzko et al., 1998) . It is likely that the P/CAF and SAGA complexes function analogously. The mammalian P/CAF protein has been shown to regulate transcription of a number of genes in a manner dependent upon its HAT activity (Blanco et al., 1998; Korzus et al., 1998; Krumm et al., 1998; McMahon et al., 1999; Puri et al., 1997) . However, a role in transcriptional regulation for the P/CAFcontaining complex as a whole has not been established, nor has the eect of E1A on P/CAF as it functions in the context of the P/CAF complex been examined. Our results showing a requirement for an intact SAGA complex for E1A function in yeast suggest the relevant target of E1A may be a function of the entire complex. Our data regarding E1A-Tra1 and E1A-Gcn5 interactions may re¯ect direct binding of E1A to Tra1, Gcn5, or both. The eects on gene expression by E1A may then be a consequence of a b Figure 6 (a) E1A function requires Taf90. Strain JR241-0 (wild-type) and the indicated taf90 derivatives were transformed with plasmids expressing either Gal4 1 ± 147 or Gal4-E1A 1 ± 82 . Serial dilutions of transformants grown in selective medium were spotted on plates and incubated at 288C for 3 days. (b) E1A function does not require the TFIID speci®c Taf proteins Taf145 or Tsm1. Wildtype, taf145 and tsm1 were transformed with plasmids expressing either Gal4 1 ± 147 or Gal4-E1A 1 ± 82 . Serial dilutions of transformants grown in selective medium were spotted on plates and incubated at 288C for 3 days Figure 7 E1A function requires Tra1. Wild-type and the indicated tra1 temperature sensitive derivatives were transformed with plasmids expressing either Gal4 1 ± 147 or Gal4-E1A 1 ± 82 . Serial dilutions of transformants grown in selective medium were spotted on plates and incubated at 288C for 3 days SAGA activity in a speci®c transcriptional context. Interestingly, Sang et al. (2001) very recently reported that histone acetyltransferase activity can be coimmunoprecipitated from yeast cells expressing E1A. This ®ts well with our demonstration of an E1A-Gcn5 interaction. It will be interesting to determine if other yeast HATs also associate with E1A.
Our observation that Tra1 is required by E1A to function in yeast is interesting in light of data regarding the mammalian homologue of Tra1, TRRAP. The TRRAP protein was identi®ed as an ATM-related cofactor for c-myc or E1A mediated transformation of primary rodent cells . TRRAP is nearly identical to the P/CAF associated factor, PAF400, thereby potentially linking transformation by E1A to transcriptional regulation by SAGA-like complexes (Vassilev et al., 1998) . We plan to use our model system to further characterize E1A dependence upon SAGA, which should provide a better understanding of Tra1 function in yeast as well as how its homologue participates in transformation by E1A in mammalian cells.
The interaction of viral activators with cellular proteins that modify chromatin structure is an emerging theme among the mechanisms of viral replication. Epstein-Barr virus nuclear antigen 2 (EBNA2) and herpes simplex virus VP16 interact with p300, CBP and P/CAF in mammalian cells. The interaction of these viral activators with p300 or CBP potentiates transcription by their acidic activation domains (Wang et al., 2000) . HIV-1 Tat protein also interacts with p300 and P/CAF and can be directly acetylated by these HATs. This modi®cation alters Tat function in stimulating transcription from viral long terminal repeats (Benkirane et al., 1998; Kiernan et al., 1999; Marzio et al., 1998) . Other viral factors such as SV40 T-antigen, papilloma E6, HTLV Tax and KSHV vIRF have been shown to interact with cellular HAT activities (Bex et al., 1998; Eckner et al., 1996; Jayachandra et al., 1999; Patel et al., 1999; Zimmermann et al., 1999) . In some cases a clear requirement for HAT activity has been demonstrated, but the coactivator functions of p300 or CBP or as yet uncharacterized functions of P/CAF could also be required by these viral activators. In the case of E1A, our data suggest that the relevant HAT target of this viral activator will be the SAGA-like macromolecular complexes in mammalian cells.
We have previously shown that E1A speci®cally inhibits SWI/SNF dependent transcription in yeast (Miller et al., 1996) . Our results showing a requirement for a functional SAGA complex are consistent with a function of E1A in regulating transcription by modulating chromatin structure and may be related to the eects of E1A on SWI/SNF. Several laboratories have observed synthetic lethal genetic interactions Boxes represent 300 amino acid segments of Tra1. These 300 amino acid sequence blocks were compared to the human TRRAP sequence using the Best Fit alignment program of the GCG Sequence Analysis Software Package. Light gray blocks are 65% similar to human TRRAP, dark gray blocks are 52 ± 55% similar. Unshaded blocks are 43 to 52% similar. K denotes the domain of Tra1 related to the kinase domain of ATM family members . Black bars represent segments of Tra1 fused to GST. (b) Immunoblot analysis of E1A co-immunoprecipitates. Whole cell lysates were prepared from strain MSY596 expressing the indicated GST-Tra1 fusion proteins in the presence (+) or absence (-) of full-length E1A 243 , and incubated with the anti-FLAG or anti-E1A antibodies as indicated. Immunoprecipitates were separated by SDS ± PAGE and analysed by Western blot using an anti-GST antibody. Also shown are anti-GST Western blots of the whole cell lysates used for immunoprecipitation between components of SAGA and SWI/SNF, suggesting a functional relationship between these complexes (Pollard and Peterson, 1997; Roberts and Winston, 1997; Sterner et al., 1999) . It has also been shown that acetylation of the N-terminal tails of histones can modify SWI/SNF function and processivity (Logie et al., 1999) , and additional genetic and biochemical interactions between SAGA and SWI/ SNF have been reported (Cosma et al., 1999; Hassan et al., 2001; Krebs et al., 2000; Syntichaki et al., 2000) . If E1A were acting here simply to ablate SAGA or SWI/SNF function, then the reported synthetic lethality observed in double mutants of SWI/SNF and SAGA would lead to the prediction that expression of E1A in cells containing single mutations that disrupt either complex, would cause death. However this is clearly not the case: cells expressing E1A but lacking either SAGA components (this work) or SWI/SNF components (Miller et al., 1996) grow well. Since SAGA and SWI/SNF interact genetically and biochemically, and since E1A can associate with components of the SAGA complex, we propose that E1A is acting at the interface between SAGA and SWI/SNF, and may be acting similarly in the mammalian context. Using our model system we will be able to use E1A as a probe for the functional and biochemical relationships between these two chromatin modifying complexes and, in addition, identify speci®c E1A binding proteins in yeast that mediate its function.
Materials and methods
acids 900 ± 1800 were ampli®ed using primers cak101 (5'-GGA TCC ATG TTA GAA TTA TGT ATT-3') and cak108 (5'-GGA TCC CTA ACC TTA TAT TCT AGC ATC CAA-3'). Amino acids 1500 ± 2400 were ampli®ed using primers cak105 (5'-GGA TCC ATG CTA TTG GAC TCA ATA-3') and cak112 (5'-GGA TCC CTA ACC CTA GAA CCA TGG CAT GAA-3'). Amino acids 2400 ± 3300 were ampli®ed with primers cak106 (5'-GGA TCC ATG GAT GCT TTA TCG AAG C-3') and cak113 (5'-GGA TCC CTA ACC TTA TTT CAA GAC TAT TTC G-3'). Amino acids 2600 ± 3745 were ampli®ed with primers cak103 (5'-GGA TCC ATG CTA TTT GAT CAA GAA C-3') and cak110 (5'-GGA TCC CTA ACC TTA AAA GTC GGC ATT GAA C-3'). GSTCasDYXXP was constructed by cloning the BamHI-XbaI fragment of pRK5 (kindly provided by Dr Amy Bouton) into the BamHI and XbaI sites of pPS892. pPS892 contains a Gal1 promoter upstream of the GST coding sequence, allowing for inducible expression of the GST-fusion proteins.
RNA analysis
RNA isolations and Northern blot analyses were performed as previously described (Miller et al., 1996) .
Construction of ada1
MSY596ada1 was constructed by disruption of ADA1 with a one-step disruption plasmid pADA1-Kan r . This plasmid was created in two steps. First, a 1288 base pair Pst1/Spe1 fragment of ADA1 from pDB20L-ADA1 (kindly provided by L Guarente) was ligated to a modi®ed pBluescript KS (Stratagene, USA) with the HindIII and EcoRV sites destroyed. This plasmid was then digested with HindIII and EcoRV within the inserted ADA1 sequence and the ends were blunted with T4 polymerase. The kanamycin resistance gene was inserted as a blunt-ended XhoI/XbaI fragment excised from plasmid pUG6 (Guldener et al., 1996) , creating a pADA1-Kan r . Digestion of this plasmid with XhoI and XbaI released the fragment of ADA1 disrupted with the kanamycin resistance gene. MSY596 was transformed with this fragment and transformants were selected on YPD medium containing 200 mg/L G418. Southern blot analysis was used to con®rm the disruption of ADA1.
TRA1 ts construction
The TRA1 ts strains were created using a plasmid shue strategy. The shue strain carried a deletion of the genomic TRA1 sequence and a URA3-marked plasmid carrying wildtype TRA1 sequence. This strain was transformed with LEU2-marked plasmid DNA carrying TRA1 sequences that had been mutagenized by hydroxylamine treatment. Leu+ transformants were screened for those that could lose the URA3-marked wild-type TRA1 plasmid by growth on 5-FOA media lacking leucine. Transformants that grew on 5-FOA were then screened for temperature sensitivity at 378C. TRA1-1 ts and TRA1-2 ts were obtained from this screen. Detailed characterization of these alleles of TRA1 will be described elsewhere.
Immunoprecipitations
For co-immunoprecipitation experiments, yeast strain MSY596 was co-transformed with pGST-Tra1 plasmids and a plasmid expressing E1A 243 or control vector. To prepare whole cell lysates, yeast transformants were grown in synthetic complete medium at 288C with glycerol and ethanol as the carbon source (2% ®nal concentration for each). At a density of approximately 1610 7 cells/ml, expression of the GST-fusion protein and E1A 243 was induced by the addition of galactose to a ®nal concentration of 2% and incubation for 5 h. Cells were collected by centrifugation and resuspended in buer HSB3 (45 mM HEPES, 300 mM NaCl, 0.1 mM EDTA, 10% glycerol, 1 mM DTT, and protease inhibitors). Glass beads (100 mm diameter, Sigma) were added to half volume and the cells were disrupted with a 2 min cycle at maximum speed in a mini-bead beater apparatus. Supernatants collected from the lysed cells were quanti®ed using the Bio-Rad protein assay. Two milligrams of whole cell lysate were immunoprecipitated in a ®nal volume of 1 ml adjusted with HSB3 and a ®nal detergent concentration of 0.1% IGEPAL (Sigma). E1A protein was immunoprecipitated with the addition of 0.1 ml of monoclonal antibody M73 supernatant. 4.4 mg anti-FLAG antibody M2 (Sigma) was used in control immunoprecipitations. Immunoprecipitations were performed at 48C for 12 h. Immune complexes were collected on Protein A-sepharose beads (Sigma), washed with HSB3 plus 0.1% IGEPAL, boiled in SDS ± PAGE sample buer and run on 8% polyacrylamide gels. Proteins were transferred to nitrocellulose and Western blotted by standard methods. GST-fusion proteins present in the anti-E1A immunoprecipitates were detected with anti-GST monoclonal antibody 9D9 (kindly provided by Dr Tom Parsons).
